Clinical Trial

Hypertonic Saline for MAC

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated August 15, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The MAC-HS study is a testing whether hypertonic saline helps improve symptoms and clearance of mycobacteria in patients with M. avium complex lung infections.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-06-04; most recent amendment 2025-08-12.
Trial Details
NCT Number NCT04921943
Lead Sponsor Oregon Health and Science University
Collaborators: NTM Info & Research, Inc., University Health Network, Toronto, New York University
Conditions Nontuberculous Mycobacterial Lung Disease, Nontuberculous Mycobacterium Infection
Enrollment 50 participants
Start Date 2021-05-18
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-15